PMA supplement
P010021 S011: VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV REAGENT PACK AND VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV CALIBRATOR
FDA PMA supplement · 30-Day Notice · Ortho-Clinical Diagnostics, Inc.
Key facts
| Original PMA | P010021 |
|---|---|
| Supplement number | S011 |
| Supplement type | 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV REAGENT PACK AND VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HCV CALIBRATOR |
| Generic name | Assay, enzyme linked immunosorbent, hepatitis c virus |
| Applicant | Ortho-Clinical Diagnostics, Inc. |
| Product code | MZO |
| Received date | Jun 5, 2007 |
| Decision date | Jun 21, 2007 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: